Industry Partner Program now available!
The APLAR 2024 official program is scheduled in the Singapore time zone (GMT+8).
To check the program times in your location, use our time zone converter.
Program is best viewed on a desktop or large landscape screen.
- Following links within the program will take you to the APLAR Congress website.
| Plenary / Concurrent 1 | ||||||
|---|---|---|---|---|---|---|
|
1700-1800 |
Opening Ceremony Included in registration. View more information here |
|||||
| Exhibition Hall | ||||||
|---|---|---|---|---|---|---|
|
1800-1930 |
Welcome Reception and Official Opening of Exhibition Hall Included in registration. View more information here |
|||||
| Plenary / Concurrent 1 | Concurrent 2 | Concurrent 3 | Concurrent 4 | |
|---|---|---|---|---|
|
0800-0915 |
|
|||
|
0915-1045 |
||||
|
1045-1110 |
Break and poster viewing |
|||
|
1110-1215 |
Morning symposium 1 Biomarkers and Data Analytics: Paving the Way for Personalized Treatment with b/tsDMARDs in Rheumatic Conditions |
Morning symposium 2
Improving Clinical outcomes in Lupus Nephritis |
Morning symposium 3
The Role of Filgotinib in The Treatment of Rheumatoid Arthristis |
Morning symposium 4
Raising the bar in RA and AxSpA: Challenges and successes of improving quality of care in Asia-Pacific |
|
|
|
|
|
|
|
1215-1330 |
|
|||
|
1330-1500 |
Lunch symposium 1
Advances in Management of CTD-ILD – Evidence Based Approach for Early Antifibrotic Treatment |
Lunch symposium 2
Direct Inhibition of IL-6 in Rheumatoid Arthritis: Accumulated Experience and Clinical Perspectives |
Break and poster viewing |
|
|
|
|
|
||
|
1500-1615 |
|
|||
|
1615-1645 |
Break and poster viewing |
|||
|
1645-1800 |
|
|||
| Plenary / Concurrent 1 | Concurrent 2 | Concurrent 3 | Concurrent 3 | |
|---|---|---|---|---|
|
0800-0915 |
|
|||
|
0915-1045 |
||||
|
1045-1110 |
Break and poster viewing |
|||
|
1110-1215 |
Morning symposium 5
From trials to clinical practice: how do today’s therapies help patients achieve their goals? |
Morning symposium 6
Early intervention to elevate management goals in SLE |
Morning symposium 7
Reshaping SLE care: Is remission now possible for the many? |
Morning symposium 8
Infliximab from IV to SC: Mainstay Therapy in Rheumatology |
|
|
|
|
|
|
|
1215-1330 |
|
|||
|
1330-1500 |
Lunch symposium 3
Emerging Insights: Innovative Therapies in Autoimmune Diseases: From Biomarker Insights to Precision Medicine |
Break and poster viewing |
||
|
|
|
|||
|
1500-1615 |
|
|||
|
1615-1645 |
Break and poster viewing |
|||
|
1645-1800 |
|
|||
| Plenary / Concurrent 1 | Concurrent 2 | Concurrent 3 | Concurrent 4 | |
|---|---|---|---|---|
|
0800-0915 |
|
|||
|
0915-1045 |
||||
|
1045-1110 |
Morning Tea |
|||
|
1100-1225 |
|
|||
|
1225-1355 |
Lunch symposium 5
The Dawn of New Era in Antiphospholipid Syndrome |
|
||
|
|
||||
|
1355-1455 |
|
|||
|
1455-1530 |
||||
